| Primary |
| Narcolepsy |
17.7% |
| Sleep Apnoea Syndrome |
16.8% |
| Depression |
9.4% |
| Fatigue |
9.3% |
| Somnolence |
8.3% |
| Hypertension |
5.1% |
| Circadian Rhythm Sleep Disorder |
4.3% |
| Hypersomnia |
3.9% |
| Anxiety |
3.1% |
| Pain |
2.7% |
| Sleep Disorder |
2.6% |
| Multiple Sclerosis |
2.4% |
| Fibromyalgia |
2.3% |
| Diabetes Mellitus |
2.1% |
| Attention Deficit/hyperactivity Disorder |
1.8% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Vitamin Supplementation |
1.7% |
| Bipolar Disorder |
1.6% |
| Hypothyroidism |
1.6% |
| Migraine |
1.5% |
|
| Drug Ineffective |
18.3% |
| Rash |
11.1% |
| Headache |
10.9% |
| Insomnia |
7.5% |
| Off Label Use |
6.7% |
| Nausea |
6.4% |
| Drug Ineffective For Unapproved Indication |
5.6% |
| Somnolence |
5.0% |
| Anxiety |
3.5% |
| Drug Tolerance |
3.0% |
| Fatigue |
2.6% |
| Urticaria |
2.4% |
| Dizziness |
2.3% |
| Feeling Abnormal |
2.2% |
| Tremor |
2.2% |
| Drug Prescribing Error |
2.2% |
| Drug Effect Decreased |
2.0% |
| Nervousness |
2.0% |
| Palpitations |
2.0% |
| Stevens-johnson Syndrome |
1.9% |
|
| Secondary |
| Sleep Apnoea Syndrome |
16.7% |
| Narcolepsy |
14.2% |
| Depression |
9.7% |
| Fatigue |
9.0% |
| Somnolence |
7.2% |
| Product Used For Unknown Indication |
6.2% |
| Hypertension |
4.6% |
| Hypersomnia |
3.8% |
| Anxiety |
3.5% |
| Fibromyalgia |
3.4% |
| Bipolar Disorder |
2.9% |
| Sleep Disorder |
2.9% |
| Attention Deficit/hyperactivity Disorder |
2.4% |
| Circadian Rhythm Sleep Disorder |
2.4% |
| Multiple Sclerosis |
2.2% |
| Pain |
1.9% |
| Hypothyroidism |
1.9% |
| Migraine |
1.9% |
| Asthenia |
1.7% |
| Blood Cholesterol Increased |
1.7% |
|
| Drug Ineffective |
21.4% |
| Drug Ineffective For Unapproved Indication |
8.7% |
| Insomnia |
7.7% |
| Off Label Use |
6.0% |
| Nausea |
5.5% |
| Headache |
5.0% |
| Somnolence |
4.7% |
| Drug Prescribing Error |
4.2% |
| Intentional Drug Misuse |
4.2% |
| Drug Tolerance |
4.0% |
| Rash |
4.0% |
| Fatigue |
3.7% |
| Psychomotor Hyperactivity |
3.2% |
| Dyspnoea |
3.0% |
| Drug Effect Increased |
2.7% |
| Personality Change |
2.7% |
| Urticaria |
2.5% |
| Feeling Jittery |
2.2% |
| Nervousness |
2.2% |
| Anxiety |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.1% |
| Multiple Sclerosis |
19.4% |
| Depression |
7.1% |
| Pain |
6.3% |
| Fatigue |
5.7% |
| Asthma |
5.0% |
| Anxiety |
3.2% |
| Hypertension |
2.6% |
| Fibromyalgia |
2.5% |
| Sleep Disorder |
2.5% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Insomnia |
2.0% |
| Rheumatoid Arthritis |
2.0% |
| Narcolepsy |
1.9% |
| Hypothyroidism |
1.6% |
| Asthenia |
1.4% |
| Restless Legs Syndrome |
1.3% |
| Bipolar Disorder |
1.2% |
| Somnolence |
1.2% |
| Relapsing-remitting Multiple Sclerosis |
1.1% |
|
| Pain |
8.7% |
| Urinary Tract Infection |
6.9% |
| Weight Decreased |
6.9% |
| Drug Ineffective |
6.4% |
| Nausea |
6.4% |
| Progressive Multifocal Leukoencephalopathy |
5.5% |
| Fatigue |
5.0% |
| Death |
4.6% |
| Depression |
4.6% |
| Multiple Sclerosis Relapse |
4.6% |
| Vision Blurred |
4.6% |
| Weight Increased |
4.6% |
| Headache |
4.1% |
| Vomiting |
4.1% |
| White Blood Cell Count Decreased |
4.1% |
| Wrong Technique In Drug Usage Process |
4.1% |
| Convulsion |
3.7% |
| Pruritus |
3.7% |
| Pulmonary Embolism |
3.7% |
| Thyrotoxic Crisis |
3.7% |
|
| Interacting |
| Schizophrenia |
75.9% |
| Sleep Disorder |
6.3% |
| Ill-defined Disorder |
3.8% |
| Attention Deficit/hyperactivity Disorder |
2.5% |
| Bipolar I Disorder |
2.5% |
| Fatigue |
2.5% |
| Restless Legs Syndrome |
2.5% |
| Depression |
1.3% |
| Narcolepsy |
1.3% |
| Somnolence |
1.3% |
|
| Drug Interaction |
28.6% |
| Rash Morbilliform |
19.0% |
| Schizophrenia |
19.0% |
| Crying |
9.5% |
| Drug Prescribing Error |
9.5% |
| Anxiety |
4.8% |
| Hospitalisation |
4.8% |
| Hypoaesthesia Oral |
4.8% |
|
